Antibody-drug conjugates, targeted protein degradation, induced proximity, bispecifics, and T-Cell Engagers have fast become the leading focus of R&D emerging from South Korea. The World Targeted Therapeutics South Korea Summit by Hanson Wade is a brand-new event experience delivering a comprehensive three-day coverage of the hottest topics in oncology by uniting three conferences together in the same venue at the same time: the 5th World ADC Summit South Korea, the World TPD & Induced Proximity Summit South Korea, and the World Bispecific & T-Cell Engager Summit South Korea.
This is a unique opportunity to focus on differentiated platforms and pipelines to create future first-and-best-in-class therapeutics that make you stand out from your competition and more appealing for global pharma partnerships.
Acting as Korea's most comprehensive R&D forum, join 450+ of your peers to transform the future and position South Korea as a global leader in targeted therapeutic R&D with both a strategic overview and technical insights across discovery, preclinical translation, clinical development, and manufacturing in each field.
What to Expect?
Cross-Modality Scientific Insight:
Whether you work on antibody-drug conjugates (ADCs), targeted protein degradation (TPD) and induced proximity, bispecifics, or T-cell engagers, gain a holistic view of how to develop next-generation targeted therapeutics.
Translational & Clinical Learnings:
Access real-world case studies and clinical data from early discovery through late-stage development, with a focus on overcoming shared challenges in efficacy, safety, and patient selection.
Strategic Partnering & Innovation Opportunities:
Connect with Korean and global pharma, biotech, and solution providers across all three modalities to identify collaboration opportunities, technology platforms, and novel combination approaches.
Future-Facing Perspectives:
Hear from industry leaders on emerging trends, regulatory considerations, and the long-term commercial outlook shaping the next era of targeted therapies.
Event Highlights
5th World ADC Summit South Korea
With 16 years of experience providing antibody-drug conjugate focused conferences around the world, and 5 years in the APAC region, World ADC Asia is your one-stop shop for ADC content from early discovery to late-phase manufacturing.
Learn, Share, Collaborate to Direct the Future Korean ADC Development
World Bispecifics & T-Cell Engager Summit South Korea
Following successfully serving the Bispecific & T-Cell Engager communities for over a decade, the World Bispecific & T-Cell Engager Summit South Korea comes to Korea for the first time as the country's only event dedicated to propelling the next-generation of differentiated bispecific and T-Cell Engager drugs.
Supercharge Bispecific & TCEs to Revolutionize Oncology Treatments
World TPD & Induced Proximity Summit South Korea
After serving the United States and European TPD communities for several years, the first World TPD & Induced Proximity Summit South Korea will bring global leaders together with Korean innovators to develop novel degradation platforms that redefine the druggable proteome.
Your One-Stop Forum to De-Risk & Develop Best-in-Class TPD Therapeutics
Download the Official Agenda to Explore:
- Your One-Stop Forum to Develop First- and Best-in-Class ADC Therapeutics
- Insights from 35+ Korean-Based and International Speakers
- Unrivalled Networking Opportunities with Professionals Working on ADCs, TPD & Induced Proximity, and Bispecifics & T-Cell Engagers
Explore the Agenda
Hear the latest ADC technology innovations taking place within South Korea and gain exclusive insights on the progress in ADC development globally.
Partner With Us
Position yourself alongside other leading solution providers to ensure your company is the go-to service providers for Korean ADC leaders.
Join Biopharma Experts
Be part of the hottest conversations with like-minded scientists, C-level executives, heads, managers, VPs, and more across discovery, clinical and CMC functions.